AstraZeneca awarded $76 million from Apotex for Prilosec generic

NEW YORK (Reuters) - A U.S. federal judge has awarded AstraZeneca Plc $76 million in damages from generic drug manufacturer Apotex for infringing upon patents for AstraZeneca's blockbuster heartburn drug, Prilosec, between 2003 and 2007.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news